Global Antibodies Market Insights, Forecast to 2025

Publisher Name :
Date: 10-Jun-2019
No. of pages: 112
Inquire Before Buying

An antibody (Ab), also known as an immunoglobulin (Ig), is a large, Y-shaped protein produced mainly by plasma cells that is used by the immune system to neutralize pathogens such as pathogenic bacteria and viruses. The antibody recognizes a unique molecule of the pathogen, called an antigen, via the Fab's variable region.

Based on types, the global antibodies market is seperated into polyclonal antibodies, monoclonal antibodies and antibody-drug conjugates. Among others, monoclonal antibodies posses the biggest market share in 2017 and is expected to increase over the forecast period.

Antibodies can be widely used in different sectorsluding hospitals, research institutions and long-term care facilities. Hospitals are the biggest downstream consumer of antibodies due to intens demand of monoclonal antibodies.

The global Antibodies market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antibodies market based on company, product type, end user and key regions.

This report studies the global market size of Antibodies in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antibodies in these regions.

This research report categorizes the global Antibodies market by top players/brands, region, type and end user. This report also studies the global Antibodies market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Novartis

- F. Hoffmann-La Roche

- Johnson & Johnson Services

- Amgen

- Bristol-Myers Squibb

- AbbVie

- Eli Lilly

Market size by Product

- Monoclonal antibodies

- Polyclonal antibodies

- Antibody drug conjugates

Market size by End User

- Hospitals

- Long-term care facilities

- Research institutes

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Antibodies market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Antibodies market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Antibodies companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Antibodies submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Antibodies are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antibodies market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Antibodies Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Antibodies Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Antibodies Market Size Growth Rate by Product
1.4.2 Monoclonal antibodies
1.4.3 Polyclonal antibodies
1.4.4 Antibody drug conjugates
1.5 Market by End User
1.5.1 Global Antibodies Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Long-term care facilities
1.5.4 Research institutes
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antibodies Market Size
2.1.1 Global Antibodies Revenue 2014-2025
2.1.2 Global Antibodies Sales 2014-2025
2.2 Antibodies Growth Rate by Regions
2.2.1 Global Antibodies Sales by Regions
2.2.2 Global Antibodies Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Antibodies Sales by Manufacturers
3.1.1 Antibodies Sales by Manufacturers
3.1.2 Antibodies Sales Market Share by Manufacturers
3.1.3 Global Antibodies Market Concentration Ratio (CR5 and HHI)
3.2 Antibodies Revenue by Manufacturers
3.2.1 Antibodies Revenue by Manufacturers (2014-2019)
3.2.2 Antibodies Revenue Share by Manufacturers (2014-2019)
3.3 Antibodies Price by Manufacturers
3.4 Antibodies Manufacturing Base Distribution, Product Types
3.4.1 Antibodies Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibodies Product Type
3.4.3 Date of International Manufacturers Enter into Antibodies Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Antibodies Sales by Product
4.2 Global Antibodies Revenue by Product
4.3 Antibodies Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Antibodies Breakdown Data by End User
6 North America
6.1 North America Antibodies by Countries
6.1.1 North America Antibodies Sales by Countries
6.1.2 North America Antibodies Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Antibodies by Product
6.3 North America Antibodies by End User
7 Europe
7.1 Europe Antibodies by Countries
7.1.1 Europe Antibodies Sales by Countries
7.1.2 Europe Antibodies Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antibodies by Product
7.3 Europe Antibodies by End User
8 Asia Pacific
8.1 Asia Pacific Antibodies by Countries
8.1.1 Asia Pacific Antibodies Sales by Countries
8.1.2 Asia Pacific Antibodies Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Antibodies by Product
8.3 Asia Pacific Antibodies by End User
9 Central & South America
9.1 Central & South America Antibodies by Countries
9.1.1 Central & South America Antibodies Sales by Countries
9.1.2 Central & South America Antibodies Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Antibodies by Product
9.3 Central & South America Antibodies by End User
10 Middle East and Africa
10.1 Middle East and Africa Antibodies by Countries
10.1.1 Middle East and Africa Antibodies Sales by Countries
10.1.2 Middle East and Africa Antibodies Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Antibodies by Product
10.3 Middle East and Africa Antibodies by End User
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Business Overview
11.1.3 Novartis Antibodies Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Novartis Antibodies Products Offered
11.1.5 Novartis Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 Company Business Overview
11.2.3 F. Hoffmann-La Roche Antibodies Sales, Revenue and Gross Margin (2014-2019)
11.2.4 F. Hoffmann-La Roche Antibodies Products Offered
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Johnson & Johnson Services
11.3.1 Johnson & Johnson Services Company Details
11.3.2 Company Business Overview
11.3.3 Johnson & Johnson Services Antibodies Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Johnson & Johnson Services Antibodies Products Offered
11.3.5 Johnson & Johnson Services Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Company Business Overview
11.4.3 Amgen Antibodies Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Amgen Antibodies Products Offered
11.4.5 Amgen Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Company Business Overview
11.5.3 Bristol-Myers Squibb Antibodies Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Bristol-Myers Squibb Antibodies Products Offered
11.5.5 Bristol-Myers Squibb Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 Company Business Overview
11.6.3 AbbVie Antibodies Sales, Revenue and Gross Margin (2014-2019)
11.6.4 AbbVie Antibodies Products Offered
11.6.5 AbbVie Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Company Business Overview
11.7.3 Eli Lilly Antibodies Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Eli Lilly Antibodies Products Offered
11.7.5 Eli Lilly Recent Development
12 Future Forecast
12.1 Antibodies Market Forecast by Regions
12.1.1 Global Antibodies Sales Forecast by Regions 2019-2025
12.1.2 Global Antibodies Revenue Forecast by Regions 2019-2025
12.2 Antibodies Market Forecast by Product
12.2.1 Global Antibodies Sales Forecast by Product 2019-2025
12.2.2 Global Antibodies Revenue Forecast by Product 2019-2025
12.3 Antibodies Market Forecast by End User
12.4 North America Antibodies Forecast
12.5 Europe Antibodies Forecast
12.6 Asia Pacific Antibodies Forecast
12.7 Central & South America Antibodies Forecast
12.8 Middle East and Africa Antibodies Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antibodies Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Antibodies Product Picture
Table Antibodies Market Segments
Table Key Manufacturers Antibodies Covered
Table Global Antibodies Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Antibodies Sales Market Share by Product 2014-2025
Figure Monoclonal antibodies Product Picture
Table Major Manufacturers of Monoclonal antibodies
Figure Polyclonal antibodies Product Picture
Table Major Manufacturers of Polyclonal antibodies
Figure Antibody drug conjugates Product Picture
Table Major Manufacturers of Antibody drug conjugates
Table Global Antibodies Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Long-term care facilities
Figure Research institutes
Figure Antibodies Report Years Considered
Figure Global Antibodies Market Size 2014-2025 (Million US$)
Figure Global Antibodies Sales 2014-2025 (K Units)
Table Global Antibodies Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Antibodies Sales by Regions 2014-2019 (K Units)
Table Global Antibodies Sales Market Share by Regions 2014-2019
Figure Global Antibodies Sales Market Share by Regions 2014-2019
Figure 2018 Global Antibodies Sales Market Share by Regions
Table Global Antibodies Revenue by Regions 2014-2019 (Million US$)
Table Global Antibodies Revenue Market Share by Regions 2014-2019
Figure Global Antibodies Revenue Market Share by Regions 2014-2019
Figure 2018 Global Antibodies Revenue Market Share by Regions
Table Global Antibodies Sales by Manufacturers (2014-2019) (K Units)
Table Global Antibodies Sales Share by Manufacturers (2014-2019)
Figure Global Antibodies Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Antibodies Revenue by Manufacturers (2014-2019) (Million USD)
Table Antibodies Revenue Share by Manufacturers (2014-2019)
Figure Antibodies Value Share by Manufacturers in 2018
Table Key Manufacturers Antibodies Price (2014-2019) (USD/Unit)
Table Antibodies Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Antibodies Product Type
Table Date of International Manufacturers Enter into Antibodies Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Antibodies Sales by Product (2014-2019) (K Units)
Table Global Antibodies Sales Share by Product (2014-2019)
Figure Global Antibodies Sales Market Share by Product (2014-2019)
Figure Global Antibodies Sales Market Share by Product in 2018
Table Global Antibodies Revenue by Product (2014-2019) (Million US$)
Table Global Antibodies Revenue Share by Product (2014-2019)
Figure Global Antibodies Revenue Market Share by Product (2014-2019)
Figure Global Antibodies Revenue Market Share by Product in 2018
Table Antibodies Price by Product 2014-2019 (USD/Unit)
Table Global Antibodies Sales by End User (2014-2019) (K Units)
Table Global Antibodies Sales Share by End User (2014-2019)
Figure Global Sales Antibodies Market Share by End User (2014-2019)
Figure Global Sales Antibodies Market Share by End User in 2018
Figure North America Antibodies Sales Growth Rate 2014-2019 (K Units)
Figure North America Antibodies Revenue Growth Rate 2014-2019 (Million US$)
Table North America Antibodies Sales by Countries (2014-2019) (K Units)
Table North America Antibodies Sales Market Share by Countries (2014-2019)
Figure 2018 North America Antibodies Sales Market Share by Countries
Table North America Antibodies Revenue by Countries (2014-2019) (Million US$)
Table North America Antibodies Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Antibodies Revenue Market Share by Countries
Figure United States Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure United States Antibodies Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Canada Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Table North America Antibodies Sales by Product (2014-2019) (K Units)
Table North America Antibodies Sales Market Share by Product (2014-2019)
Figure 2018 North America Antibodies Market Share by Product
Table North America Antibodies Sales by End User (2014-2019) (K Units)
Table North America Antibodies Sales Market Share by End User (2014-2019)
Figure 2018 North America Antibodies Market Share by End User
Figure Europe Antibodies Sales Growth Rate 2014-2019 (K Units)
Figure Europe Antibodies Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Antibodies Sales by Countries (2014-2019) (K Units)
Table Europe Antibodies Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Antibodies Sales Market Share by Countries
Table Europe Antibodies Revenue by Countries (2014-2019) (Million US$)
Table Europe Antibodies Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Antibodies Revenue Market Share by Countries
Figure Germany Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Germany Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure France Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure France Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure UK Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Italy Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Russia Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Antibodies Sales by Product (2014-2019) (K Units)
Table Europe Antibodies Sales Market Share by Product (2014-2019)
Figure 2018 Europe Antibodies Market Share by Product
Table Europe Antibodies Sales by End User (2014-2019) (K Units)
Table Europe Antibodies Sales Market Share by End User (2014-2019)
Figure 2018 Europe Antibodies Market Share by End User
Figure Asia Pacific Antibodies Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Antibodies Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Antibodies Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Antibodies Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Antibodies Sales Market Share by Countries
Table Asia Pacific Antibodies Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Antibodies Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Antibodies Revenue Market Share by Countries
Figure China Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure China Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Japan Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Korea Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure India Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure India Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Australia Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Antibodies Sales by Product (2014-2019) (K Units)
Table Asia Pacific Antibodies Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Antibodies Market Share by Product
Table Asia Pacific Antibodies Sales by End User (2014-2019) (K Units)
Table Asia Pacific Antibodies Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Antibodies Market Share by End User
Figure Central & South America Antibodies Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Antibodies Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Antibodies Sales by Countries (2014-2019) (K Units)
Table Central & South America Antibodies Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Antibodies Sales Market Share by Countries
Table Central & South America Antibodies Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Antibodies Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Antibodies Revenue Market Share by Countries
Figure Brazil Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Antibodies Sales by Product (2014-2019) (K Units)
Table Central & South America Antibodies Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Antibodies Market Share by Product
Table Central & South America Antibodies Sales by End User (2014-2019) (K Units)
Table Central & South America Antibodies Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Antibodies Market Share by End User
Figure Middle East and Africa Antibodies Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Antibodies Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Antibodies Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Antibodies Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Antibodies Sales Market Share by Countries
Table Middle East and Africa Antibodies Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Antibodies Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Antibodies Revenue Market Share by Countries
Figure GCC Countries Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Antibodies Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Antibodies Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Antibodies Market Share by Product
Table Middle East and Africa Antibodies Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Antibodies Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Antibodies Market Share by End User
Table Novartis Company Details
Table Novartis Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Johnson & Johnson Services Company Details
Table Johnson & Johnson Services Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Services Recent Development
Table Amgen Company Details
Table Amgen Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table AbbVie Company Details
Table AbbVie Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Recent Development
Table Global Antibodies Sales Forecast by Regions 2019-2025 (K Units)
Table Global Antibodies Sales Market Share Forecast by Regions 2019-2025
Table Global Antibodies Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Antibodies Revenue Market Share Forecast by Regions 2019-2025
Table Global Antibodies Sales Forecast by Product 2019-2025 (K Units)
Table Global Antibodies Sales Market Share Forecast by Product 2019-2025
Table Global Antibodies Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Antibodies Revenue Market Share Forecast by Product 2019-2025
Table Global Antibodies Sales Forecast by End User 2019-2025 (K Units)
Table Global Antibodies Sales Market Share Forecast by End User 2019-2025
Figure North America Antibodies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Antibodies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Antibodies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Antibodies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Antibodies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Antibodies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Antibodies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Antibodies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Antibodies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Antibodies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Antibodies Value Chain
Table Antibodies Customers List
Table Antibodies Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs